MedTrace Logo

Effect of Psychoeducation -Based Motivational Interviewing on Knowledge and Hope in Schizophrenia

NCT07365982 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 44

Last updated 2026-01-26

No results posted yet for this study

Summary

This study aimed to examine the effect of a psychoeducation-based motivational interviewing intervention on schizophrenia-related knowledge and hope levels among patients diagnosed with schizophrenia. The study employed a randomized controlled experimental design with pre-test, post-test, and one-month follow-up measurements. Participants were recruited from a community mental health center and assigned to an intervention group or a control group. The intervention group participated in a structured psychoeducation-based motivational interviewing program consisting of one preparatory session followed by five main sessions, while the control group continued to receive routine community mental health services. Knowledge about schizophrenia and hope levels were assessed using validated measurement tools.

Conditions

Interventions

BEHAVIORAL

Psychoeducation-Based Motivational Interviewing

A structured psychoeducation-based motivational interviewing program delivered in weekly sessions lasting approximately 60-90 minutes, consisting of one preparatory session followed by five main sessions.

Sponsors & Collaborators

  • Büşra Taşkıner

    lead OTHER

Principal Investigators

  • Ceren Aycanoğlu, Assoc. Prof. Dr. · Okan University

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
SINGLE
Model
PARALLEL

Eligibility

Min Age
18 Years
Max Age
65 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2025-04-21
Primary Completion
2025-06-30
Completion
2025-06-30

Countries

  • Turkey (Türkiye)

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT07365982 on ClinicalTrials.gov